
Clinical trial result
appetite and body-fat reduction vs placebo
Six-week randomized placebo-controlled trial.
What it does
Addresses the neurochemical deficit, not the symptom of overeating.
Published research on serotonin-pathway involvement in appetite regulation.
No caffeine, no amphetamine class, no cardiovascular load.
Randomized placebo-controlled trial showed appetite and body-fat reduction vs placebo.
The mechanism
Supplies the amino acid precursors your brain needs to produce serotonin — the satiety neurotransmitter that's often depleted in patients with obesity.
Vs traditional approach
Mechanism
Cardiovascular load
Sleep impact
Addresses nutritional deficit
What's inside
5-HTP
Serotonin precursor supporting satiety
L-Glutamine
Addresses amino acid deficits documented in obesity
L-Tyrosine
Dopamine precursor for motivation and mood
Choline bitartrate
Metabolic cofactor
How to use it
30 min before meals
2 capsules mid-morning and mid-afternoon. Optional 2 in the evening.
Week 2
Most patients notice reduced between-meal cravings first.
Pair with
Most effective as part of a physician-guided weight management plan, not as standalone.
Patient outcome
“I was grazing every hour. Two weeks on AppTrim and the constant hunger noise finally got quieter.”
Ines Brewer
· age 51Your guarantee
Your clinician stays in the loop
Every AppTrim order is logged to your practitioner's dashboard. Questions route back to them first, not to a chatbot.
Free shipping after the first bottle
Auto-refill shipping is included. Cancel from your patient portal any time.
30-day satisfaction window
Not feeling a change? Your practitioner can swap you to a different formulation within the first 30 days.
120 ct
Dietary management of obesity, morbid obesity, and metabolic syndrome
A weight-management encapsulated medical food intended to support appetite control and metabolism under physician supervision. AppTrim addresses the neurochemical imbalances that drive overeating and metabolic dysfunction rather than relying on stimulants or appetite suppressants.
Key differentiator
Best positioned for weight-management support and appetite control in obesity or metabolic syndrome
Suggested retail
$54.95
AppTrim supplies amino acid precursors that modulate neurotransmitter activity involved in appetite regulation and metabolic function. The formulation targets the neurochemical deficits linked to obesity and metabolic syndrome.
2 capsules twice daily mid-morning and mid-afternoon; may add 2 capsules in the evening; take without food.
No significant drug interactions reported. Non-stimulant formulation. Ingredients are GRAS. Use under physician supervision.
A six-week randomized placebo-controlled trial demonstrated statistically significant appetite reduction and body-fat reduction in the AppTrim group versus placebo.
Peer-reviewed studies supporting AppTrim.
Set up your branded storefront in under 5 minutes. Our AI handles everything else.
See it in action